Dr. Roman A. Shingarev, MD

Dr. Shingarev practices at Wasatch Vascular Care - Salt Lake City in Salt Lake City, Utah.

Dr. Shingarev's NPI, 1457564601, was assigned on May 7, 2007. Dr. Shingarev holds Utah license 13466615-1205.

Dr. Shingarev's primary practice is Wasatch Vascular Care - Salt Lake City, at 3702 S State Street Suite 103, Salt Lake City, UT 84115. The practice phone is (727) 916-1278.

Dr. Shingarev's primary practice is Wasatch Vascular Care - Salt Lake City in Salt Lake City, Utah. Dr. Shingarev is also affiliated with Intermountain Medical Center. The medical group on file is Nephrology Associates of Utah. Dmand AI also links Dr. Shingarev to 4 more hospitals, 2 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shingarev practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Shingarev's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Shingarev's licenses on file in 3 states: Utah, Alabama and Ohio.

CMS data shows 633 Medicare services from Dr. Shingarev across 11 procedure codes in 2024, for 216 Medicare patients. Medicare paid $78,457 for them.

CMS counts 216 Medicare patients who saw Dr. Shingarev in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 21% are also on Medicaid. Their average risk score is 4.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shingarev's median patient age at 69, with 46% women.

In 2024, Dr. Shingarev wrote 599 Medicare Part D claims for 169 patients. 87% of them were for generic drugs. CMS names the drug for 459 of them, across 15 drugs with 11 or more claims each, at $54,444 in total drug cost. In 2023, CMS named 302 claims across 10 drugs.

Dr. Shingarev accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 18 papers to Dr. Shingarev, published from 2010 to 2024. 2017 was the busiest year, with 3. The most frequent topics are Renal Dialysis, Arteriovenous Shunt, Surgical and Catheterization, Central Venous. Dr. Shingarev has published most often in Am J Kidney Dis. Dr. Shingarev's most frequent co-authors are Michael Allon, Tushar Jitendra Vachharajani, MD and Jonathan Andrew Coleman, MD.

CMS Open Payments shows 82 general payments to Dr. Shingarev from 21 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 99% of the total. Amgen Inc. paid the most, $305.